High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation
- PMID: 15830008
- DOI: 10.1038/sj.leu.2403758
High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
